Practices
BioPharma
We work closely with pharma and biotech clients, with a particular focus on growth strategies - corporate, commercial, M&A and licensing. We are especially deep on perhaps the most vital aspect of BioPharma: New Product Launches.
Diagnostics
We have significant experience in the Diagnostics space, having spent a number of years advising some of the large players. We also bring depth in Genomics across oncology (germline, somatic, CGP, MCED, MRD, liquid biopsy, single-cell) and rare disease (WES, WGS), as well as Pathology (spatial, IHC, mIF) with expertise in strategic partnerships, tech transfers, M&A, licensing and bioinformatics.
Healthcare Providers and Payors
BioStratis advises large health systems, healthcare providers and payors on traditional strategic imperatives such as enhancing the patient journey while delivering efficiencies, as well as on cutting-edge growth opportunities (maximizing value from data, optimally harnessing AI and analytics).
MedTech
With experience ranging from small start-ups commercializing their first medical device up to Fortune 500 players including Medtronic and Becton Dickinson, we develop strategic plans and identify potential partnerships to drive medtech growth.
Venture Capital & Private Equity
We work with VC and PE sponsors focused on healthcare, life sciences, diagnostics and genomics to drive EBITDA growth acceleration in their portfolio companies through identification of fit-for-purpose growth plays, leveraging a portfolio approach covering R&D, licensing and M&A.
We are data-driven, analytics heavy
Across all practices and starting with the big picture, we identify relevant hypotheses to test, leverage data and analytics, and drive to logical, objective conclusions to maximize value creation for your business.